We subsequently demonstrated that AD4-GHPE has tumor-specific cytotoxicity and enhances CD8+ T-cell immune responses by reducing PD-L1 expression in breast and hypopharyngeal cancer PDOs. The gene discussed is CD8A; the disease is neoplasm.